Skip to main content
NVDA+0.02%AAPL+0.11%GOOGL-3.15%MSFT-0.05%AMZN+0.11%TSM-4.52%SPCX-9.14%META-0.55%AVGO-4.31%TSLA-0.45%LLY+2.83%BRK-B+1.50%MU-1.37%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK+0.42%1398.HK-1.87%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-27.86%3988.HK-1.38%HD+4.33%CAT-4.89%0005.HK-1.14%PM+2.17%HSBA.L-2.45%0857.HK-0.52%GE-0.79%AP2d-6.79%1288.HK-1.75%0939.HK-0.69%AMAT-8.16%NVS+1.52%MS-1.63%LRCX-11.76%EURAUD-1.27%EURCAD-1.16%AUDUSD+1.09%EURJPY-1.00%USDCAD-0.97%EURNZD-0.87%USDTHB+0.85%USDJPY-0.85%EURGBP-0.72%NZDUSD+0.71%AUDCHF+0.67%EURCHF-0.59%CADCHF+0.56%GBPAUD-0.54%GBPUSD+0.54%GBPCAD-0.45%CHFJPY-0.45%USDTRY+0.43%USDCHF-0.42%GBPTRY+0.41%AUDNZD+0.39%GBPHKD+0.32%GBPJPY-0.30%AUDJPY+0.29%NZDCHF+0.28%GBPMXN-0.28%NZDCAD-0.27%USDCNH-0.21%GBPNZD-0.18%NZDMXN+0.18%EURUSD-0.18%USDILS+0.16%NZDSGD+0.16%CADJPY+0.15%CHFNOK-0.15%NZDJPY-0.14%USDNOK-0.13%AUDCAD+0.12%GBPCHF+0.12%USDHKD-0.10%EURNOK-0.10%AUDNOK-0.10%EURHKD+0.07%EURZAR+0.07%NOKJPY+0.07%PLNJPY-0.06%GBPZAR+0.05%SGDJPY-0.05%CHFSEK-0.05%USDCOP-0.04%USDZAR+0.04%USDDKK-0.03%EURPLN+0.03%USDSEK-0.03%EURSGD+0.02%AUDSGD+0.02%EURCNH+0.02%CHFSGD-0.02%USDMXN+0.02%EURCZK+0.01%USDSGD-0.01%GBPSGD+0.01%USDPLN0.00%AUDDKK0.00%EURDKK0.00%EURSEK0.00%W1+0.90%GAGUSD-0.87%XAGUSD-0.86%USOIL+0.72%UKOIL+0.52%XAUUSD-0.31%GAUUSD-0.31%XNGUSD+0.22%XPTUSD+0.11%C1+0.11%S1+0.10%HG1+0.07%BTCUSD-3.09%ETHUSD+16.36%USDTUSD-0.03%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.32%ZECUSDT-7.14%DOGEUSD+14.39%XMRUSDT-2.05%LINKUSD+14.52%XLMUSD-4.04%BCHUSDT-2.27%LTCUSD+8.69%UNIUSD-5.34%SUIUSD-4.67%HBARUSDT-4.27%TONUSD+26.39%TAOUSDT-4.42%AAVEUSD-4.55%DOTUSDT-1.12%ICPUSDT-5.39%WLDUSDT-4.47%ONDOUSDT-6.02%ARBUSDT-3.92%JUPUSDT-4.25%ATOMUSDT-0.12%INJUSDT-7.41%STXUSDT-10.30%TIAUSDT-6.40%FETUSDT-4.54%PYTHUSDT-8.21%SEIUSDT-7.66%IMXUSDT-6.63%GRTUSDT-4.16%OPUSDT-7.98%WIFUSDT-5.57%IOTAUSDT-4.11%AXSUSDT-4.89%POLUSDT-3.49%FARTCOINUSDT-3.87%EOSUSDT-0.55%DYDXUSDT-5.04%GALAUSDT-4.06%ORDIUSDT-1.95%RONINUSDT-3.56%NOTUSDT-4.94%NVDA+0.02%AAPL+0.11%GOOGL-3.15%MSFT-0.05%AMZN+0.11%TSM-4.52%SPCX-9.14%META-0.55%AVGO-4.31%TSLA-0.45%LLY+2.83%BRK-B+1.50%MU-1.37%WMT+2.82%SKHY-8.07%JPM+0.40%AMD-8.10%V+1.59%XOM+0.08%JNJ+3.81%ASMLa-4.74%MA+1.70%ABBV+0.03%INTC-8.04%COST+1.99%CVX-0.04%0700.HK+0.42%1398.HK-1.87%CSCO-2.21%KO+2.87%PG+5.58%UNH+1.91%ORCL-2.80%BAC+0.59%1816.HK-27.86%3988.HK-1.38%HD+4.33%CAT-4.89%0005.HK-1.14%PM+2.17%HSBA.L-2.45%0857.HK-0.52%GE-0.79%AP2d-6.79%1288.HK-1.75%0939.HK-0.69%AMAT-8.16%NVS+1.52%MS-1.63%LRCX-11.76%EURAUD-1.27%EURCAD-1.16%AUDUSD+1.09%EURJPY-1.00%USDCAD-0.97%EURNZD-0.87%USDTHB+0.85%USDJPY-0.85%EURGBP-0.72%NZDUSD+0.71%AUDCHF+0.67%EURCHF-0.59%CADCHF+0.56%GBPAUD-0.54%GBPUSD+0.54%GBPCAD-0.45%CHFJPY-0.45%USDTRY+0.43%USDCHF-0.42%GBPTRY+0.41%AUDNZD+0.39%GBPHKD+0.32%GBPJPY-0.30%AUDJPY+0.29%NZDCHF+0.28%GBPMXN-0.28%NZDCAD-0.27%USDCNH-0.21%GBPNZD-0.18%NZDMXN+0.18%EURUSD-0.18%USDILS+0.16%NZDSGD+0.16%CADJPY+0.15%CHFNOK-0.15%NZDJPY-0.14%USDNOK-0.13%AUDCAD+0.12%GBPCHF+0.12%USDHKD-0.10%EURNOK-0.10%AUDNOK-0.10%EURHKD+0.07%EURZAR+0.07%NOKJPY+0.07%PLNJPY-0.06%GBPZAR+0.05%SGDJPY-0.05%CHFSEK-0.05%USDCOP-0.04%USDZAR+0.04%USDDKK-0.03%EURPLN+0.03%USDSEK-0.03%EURSGD+0.02%AUDSGD+0.02%EURCNH+0.02%CHFSGD-0.02%USDMXN+0.02%EURCZK+0.01%USDSGD-0.01%GBPSGD+0.01%USDPLN0.00%AUDDKK0.00%EURDKK0.00%EURSEK0.00%W1+0.90%GAGUSD-0.87%XAGUSD-0.86%USOIL+0.72%UKOIL+0.52%XAUUSD-0.31%GAUUSD-0.31%XNGUSD+0.22%XPTUSD+0.11%C1+0.11%S1+0.10%HG1+0.07%BTCUSD-3.09%ETHUSD+16.36%USDTUSD-0.03%XRPUSD+9.91%SOLUSD+10.75%TRXUSDT-0.32%ZECUSDT-7.14%DOGEUSD+14.39%XMRUSDT-2.05%LINKUSD+14.52%XLMUSD-4.04%BCHUSDT-2.27%LTCUSD+8.69%UNIUSD-5.34%SUIUSD-4.67%HBARUSDT-4.27%TONUSD+26.39%TAOUSDT-4.42%AAVEUSD-4.55%DOTUSDT-1.12%ICPUSDT-5.39%WLDUSDT-4.47%ONDOUSDT-6.02%ARBUSDT-3.92%JUPUSDT-4.25%ATOMUSDT-0.12%INJUSDT-7.41%STXUSDT-10.30%TIAUSDT-6.40%FETUSDT-4.54%PYTHUSDT-8.21%SEIUSDT-7.66%IMXUSDT-6.63%GRTUSDT-4.16%OPUSDT-7.98%WIFUSDT-5.57%IOTAUSDT-4.11%AXSUSDT-4.89%POLUSDT-3.49%FARTCOINUSDT-3.87%EOSUSDT-0.55%DYDXUSDT-5.04%GALAUSDT-4.06%ORDIUSDT-1.95%RONINUSDT-3.56%NOTUSDT-4.94%
GH

Guardant Health, Inc. (GH)

NASDAQ • Healthcare

$162.94
-$3.71 (-2.2%)
Market closed

Last close at October 22, 2026 at 20:00 UTC

Open$165.03
Day Range$158.68 - $167.25
Avg. Volume (3M)1.7M
Market Cap$21.8B
52 Week Range
$68.02$191.05
Next EarningsIn 13 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$334.9M100%
Gross Profitminus cost of goods$219M65%

In plain terms: out of every $100 in revenue, Guardant Health, Inc. currently loses $36.

Fundamentals & Financials

Revenue (TTM)
$1.1B
Net Income (TTM)
-$453.4M
EPS (TTM)
-$3.49
ROA (TTM)
-23.71%
Current Ratio
4.03

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-30.4%Q1 2026-$1
-5.5%Q2 2026-$0.85
-18.1%Q3 2026-$0.9
Next

Nov 5

in 13 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -18.1%

Guardant Health’s revenue topped consensus while EPS trailed in the second fiscal quarter of 2026, with results reported on July 30. Revenue of $335.0 million against a $314.2 million estimate topped consensus, +6.6%, and revenue rose 44.3% to about $335.0 million from $232.1 million a year ago. Gross margin held near 65%, but operating margin was about -39% as operating income came in at about -$129.1 million. EPS of -$0.90 trailed the -$0.76 estimate, -18%, and was down 12.5% from -$0.80 a year ago. Net loss was about $120.1 million, down 20.3% from about $99.9 million a year ago, and operating cash flow was negative about $57.8 million. For the next period, consensus calls for EPS of -$0.28 on revenue of $349.3 million.

Next report — what to expect

Guardant Health, Inc. (GH) reports on October 28, 2026. The market is expecting EPS of -$0.29 on revenue of $350.8 million. For trailing context, revenue grew +44.3% year over year last quarter. GH has beaten EPS in 2 of 8 most recent quarters, so watch for variance versus consensus.

View full earnings history

About Guardant Health, Inc.

Guardant Health, Inc. develops blood- and tissue-based cancer testing and related research tools in the healthcare diagnostics business. Listed on NASDAQ as GH, the company generated $982.0 million of revenue in FY2025 from precision-oncology assays, biopharma services, and supporting platforms used in the United States and abroad.

Name
Guardant Health, Inc.
CEO
Helmy Eltoukhy
Website
guardanthealth.com
Industry
Healthcare
Year Founded
2011
Employees
2,498

Today's Snapshot

AI-generated

GH closed 2.2% lower at 162.94, against a firmer sector. Guardant Health will present 25 research abstracts at a major cancer conference. GH is due to report earnings on 5 November.

Trading Volume

Above 10d avg 1.6M

1.7M

vs S&P 500 Today

Underperforming Market

-0.97%

Updated: October 22, 2026 at 20:25 UTC

GH Headlines

Guardant ordered to pay TwinStrand damages

August 24, 2026

3 min read
View All News

Technical Indicators

2 Buy2 Neutral4 Sell
GH shows a weak directional backdrop while evidence leans toward selling: short- and medium-term moving averages sit above the current price near 163, while longer-term 200-day averages remain well below, indicating a mixed time-frame bias. Momentum indicators are soft, with MACD and a negative short-term momentum reading supporting downside pressure even as RSI sits near neutral. Trend strength is muted (low ADX) but volatility is meaningful given an ATR around 8.5, and on-balance volume is biased to the downside. Technical takeaway: Sell.
All signals
  • EMA (5 indicators)$133.63 - $166.60
    Sell
  • RSI (14)45.59
    Neutral
  • Stochastic %K (14, 3, 3)25.14
    Neutral
  • MACD Level (12, 26)-2.18
    Sell

Peers & Related Assets

NTRANatera, Inc.
$401.37-2.9%
GRALGRAIL Inc.
$127.06-4.2%
NEONeoGenomics, Inc.
$16.39-3.8%
CSTLCastle Biosciences, Inc.
$33.19-3.4%
MYGNMyriad Genetics, Inc.
$5.76+3.4%
FLGTFulgent Genetics, Inc.
$19.99-0.7%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.